ACSL6 and hematopoietic and lymphoid system neoplasm: Myeloid neoplasms with t(5;12) and ETV6-ACSL6 gene fusion are rare, poorly characterized hematologic neoplasms with an aggressive clinical course characterized by eosinophilic and/or basophilic leukocytosis.